TrialCancer immunology, immunotherapy : CII2014

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.

Volker Lennerz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.